The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size

The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lanreotide on tumour size

Introduction At present, there is no approved medical treatment option for patients with non-functioning pituitary adenoma. A number of open-label studies suggest that treatment with somatostatin analogues may prevent tumour progression. In vivo somatostatin receptor imaging using 68Ga-DOTATATE PET...

Full description

Bibliographic Details
Main Authors: Charles B L M Majoie, Michael W T Tanck, Jan Booij, Suat Simsek, Tessel M Boertien, Madeleine L Drent, Marcel P M Stokkel, Jantien Hoogmoed, Alberto Pereira, Ronald Groote Veldman, Eric Fliers, Peter H Bisschop
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/8/e038250.full

Internet

https://bmjopen.bmj.com/content/10/8/e038250.full

Similar Items